Table 2 Clinical data on DEB-TACE.

Median dose of THP, mg

60 (IQR 40, 60)

CB 100–300 μm

17 (48.6%)

CB 300–500 μm

18 (51.4%)

Polyvinyl alcohol 350–560 μm

25 (71.4%)

Median inpatient duration, days

14.0 (9.0, 17.5)

Mean cost of hospitalization, × 10⁴¥

5.7 ± 2.3 (3.5–16.5)

Other treatments, n (%)

 Bronchial transarterial chemoembolization

1 (2.9%)

 Inferior venae cava filter

2 (5.7%)

 Esophageal stenting

1 (2.9%)

 Ureter drainage tube placement

1 (2.9%)

 ¹²⁵I seeds implantation

2 (5.7%)

 Thermal ablation

4 (11.4%)